Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Otsuka Pharma and Click Therapeutics enter partnership poised to transform mental healthcare

Otsu­ka, Click Ther­a­peu­tics part­ner to cre­ate ther­a­py for men­tal ill­ness (Ver­dict Med­ical Devices):

Otsu­ka Pharmaceutical’s US divi­sion Otsu­ka Amer­i­ca has part­nered with Click Ther­a­peu­tics to devel­op and com­mer­cialise a pre­scrip­tion dig­i­tal ther­a­peu­tic for treat­ing major depres­sive dis­or­der (MDD) Read the rest of this entry »

Transcranial Direct Current Stimulation shows early promise to ameliorate depression, especially if combined with other therapies and dosage optimized

___

Tran­scra­nial Direct Cur­rent Stim­u­la­tion Promis­ing for Major Depres­sive Dis­or­der (Psy­chi­a­try Advi­sor):

Tran­scra­nial direct cur­rent stim­u­la­tion (tDCS) is an inves­tiga­tive modal­i­ty for major depres­sive dis­or­der (MDD) that has shown some promis­ing results. Though it has a while before it is approved by the US Food and Drug Admin­is­tra­tion, clin­i­cians and patients have been clam­or­ing for an effec­tive treat­ment for MDD that is not asso­ci­at­ed with harm­ful adverse effects. Read the rest of this entry »

FDA clears deep transcranial magnetic stimulation device to treat obsessive-compulsive disorder

___

BrainsWay’s Brain Stim­u­la­tion Device Receives FDA Approval to Treat Obses­sive-Com­pul­sive Dis­or­der (IEEE Spec­trum):

In 2013, Jerusalem-based Brain­sWay began mar­ket­ing a new type of brain stim­u­la­tion device that uses mag­net­ic puls­es to treat major depres­sive dis­or­der.

Now, thanks to pos­i­tive results in a study of 100 patients, the com­pa­ny has received approval from the U.S. Food and Drug Admin­is­tra­tion (FDA) to mar­ket the device for a sec­ond psy­chi­atric condition—obsessive-compulsive dis­or­der (OCD) Read the rest of this entry »

Systematic evidence review finds cognitive behavioral therapy as effective as antidepressant medicines in treating depression

mentalhealthtreatmentsDepres­sion: Treat­ment Beyond Med­ica­tion (The Dana Foun­da­tion):

Major depres­sive dis­or­der affects near­ly 7 per­cent of peo­ple in the US aged 18 and up, accord­ing to the Depres­sion and Bipo­lar Sup­port Alliance. Those who seek treat­ment will most like­ly be pre­scribed a sec­ond-gen­er­a­tion anti­de­pres­sant med­ica­tion such as a selec­tive sero­tonin reup­take inhibitor (SSRI), tri­cyclic anti­de­pres­sant (TCA), or a monoamine oxi­dase inhibitor (MAOI). Some recent stud­ies, though, Read the rest of this entry »

Study: Combining aerobic and mental training can significantly improve mental and cognitive health

mental_physical_training(Editor’s Note: Hat tip to co-author Tj Shors for bring­ing this fas­ci­nat­ing new study to our atten­tion)

It is wide­ly accept­ed that aer­o­bic exer­cise and med­i­ta­tion train­ing are use­ful behav­ioral ther­a­pies for reme­di­at­ing clin­i­cal symp­toms of depres­sion. How­ev­er, no study to date has assessed the com­bined effects of the two behav­ioral inter­ven­tions. Here, we present data indi­cat­ing that Read the rest of this entry »

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters and more, SharpBrains is an independent market research firm tracking health and performance applications of brain science.

Follow us and Engage via…

twitter_logo_header
RSS Feed

Search for anything brain-related in our article archives

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.